Europe Active Pharmaceutical Ingredients (API) Market 2020-2026 by Synthesis (Synthetic, Biotech, HPAPI), Manufacturing Process (Captive, Merchant), Therapeutic Application, Drug Type, and Country: Trend Forecast and Growth Opportunity
- GRA3911706
- 133 Pages
- June 2020
- Healthcare
Highlighted with 41 tables and 66 figures, this 133-page report “Europe Active Pharmaceutical Ingredients (API) Market 2020-2026 by Synthesis (Synthetic, Biotech, HPAPI), Manufacturing Process (Captive, Merchant), Therapeutic Application, Drug Type, and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Europe API market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2015-2019 and provides forecast from 2020 till 2026 with 2019 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces
The trend and outlook of Europe market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Europe API market in every aspect of the classification from perspectives of Synthesis, Manufacturing Process, Therapeutic Application, Drug Type, and Country.
Based on Synthesis, the Europe market is segmented into the following sub-markets with annual revenue for 2015-2026 included in each section.
Synthetic API
• Branded Synthetic API
• Generic Synthetic API
Biotech API by Drug Type:
• Monoclonal Antibodies
• Recombinant Proteins
• Vaccines
• Other Biotech APIs
Biotech API by Customer Base:
• Innovative Biologic API
• Generic Biosimilar API
Biotech API by Expression Technology:
• Mammalian Expression
• Microbial Expression
• Yeast Expression
• Insect Expression
• Other Expression Technologies
HPAPI
• Branded HPAPI
• Generic HPAPI
Based on Manufacturing Process, the Europe market is segmented into the following sub-markets with annual revenue for 2015-2026 included in each section.
Captive Manufacturing
• Branded Captive API
• Generic Captive API
Merchant Manufacturing by Drug Type:
• Branded Merchant API
• Generic Merchant API
Merchant Manufacturing by Drug Synthesis:
• Merchant Synthetic API
• Merchant Biotech API
Based on Therapeutic Application, the Europe market is segmented into the following sub-markets with annual revenue for 2015-2026 included in each section.
• Infectious Diseases
• Oncology
• Ophthalmology
• Cardiovascular Disorders
• Central Nervous System
• Pulmonary Disorders
• Orthopedics
• Other Applications
Based on Drug Type, the Europe market is segmented into the following sub-markets with annual revenue for 2015-2026 included in each section.
• Branded Prescription Drugs
• Generic Prescription Drugs
• OTC Drugs
Geographically, the following national/local markets are fully investigated:
• Germany
• UK
• France
• Spain
• Italy
• Russia
• Rest of Europe (further segmented into Belgium, Denmark, Austria, Norway, Sweden, The Netherlands, Poland, Czech Republic, Slovakia, Hungary, and Romania)
For each aforementioned country, detailed analysis and data for annual revenue are available for 2015-2026. The breakdown of key national markets by Synthesis, Manufacturing Process, and Therapeutic Application over the forecast years are also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Specifically, potential risks associated with investing in Europe API market are assayed quantitatively and qualitatively through GMD’s Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.
Key Players (this may not be a complete list and extra companies can be added upon request):
AbbVie Inc.
Astrazeneca
Aurobindo Pharma Ltd.
Bayer Healthcare
Bioniche Animal Health
Boehringer Ingelheim
Bristol-Myers Squibb
Ceva Animal Health, Inc.
Elanco Animal Health
Eli Lilly and Company
F. Hoffmann-La Roche
Glaxosmithkline PLC
Heska Co.
Lonza Group
Merck & Co., Inc.
Novartis International AG
Pfizer, Inc.
Ranbaxy Laboratories
Sanofi
Sun Pharmaceutical Industries Ltd.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
1.1 Industry Definition and Research Scope 7
1.1.1 Industry Definition 7
1.1.2 Research Scope 8
1.2 Research Methodology 11
1.2.1 Overview of Market Research Methodology 11
1.2.2 Market Assumption 12
1.2.3 Secondary Data 12
1.2.4 Primary Data 12
1.2.5 Data Filtration and Model Design 14
1.2.6 Market Size/Share Estimation 15
1.2.7 Research Limitations 16
1.3 Executive Summary 17
2 Market Overview and Dynamics 19
2.1 Market Size and Forecast 19
2.2 Major Growth Drivers 20
2.3 Market Restraints and Challenges 24
2.4 Emerging Opportunities and Market Trends 27
2.5 Porter’s Fiver Forces Analysis 31
3 Segmentation of Europe Market by Synthesis 35
3.1 Market Overview by Synthesis 35
3.2 Synthetic API 37
3.2.1 Branded Synthetic API 38
3.2.2 Generic Synthetic API 39
3.3 Biotech API 40
3.3.1 Biotech API by Drug Type 41
3.3.1.1 Monoclonal Antibodies 42
3.3.1.2 Recombinant Proteins 43
3.3.1.3 Vaccines 44
3.3.1.4 Other Biotech APIs 45
3.3.2 Biotech API by Customer Base 46
3.3.2.1 Innovative Biologic API 47
3.3.2.2 Generic Biosimilar API 48
3.3.3 Biotech API by Expression Technology 49
3.3.3.1 Mammalian Expression 50
3.3.3.2 Microbial Expression 51
3.3.3.3 Yeast Expression 52
3.3.3.4 Insect Expression 53
3.3.3.5 Other Expression Technologies 54
3.4 HPAPI 55
3.4.1 Branded HPAPI 56
3.4.2 Generic HPAPI 57
4 Segmentation of Europe Market by Manufacturing Process 58
4.1 Market Overview by Manufacturing Process 58
4.2 Captive Manufacturing 60
4.2.1 Branded Captive API 61
4.2.2 Generic Captive API 62
4.3 Merchant Manufacturing 63
4.3.1 Merchant Manufacturing by Drug Type 64
4.3.1.1 Branded Merchant API 65
4.3.1.2 Generic Merchant API 66
4.3.2 Merchant Manufacturing by Drug Synthesis 67
4.3.2.1 Merchant Synthetic API 68
4.3.2.2 Merchant Biotech API 69
5 Segmentation of Europe Market by Therapeutic Application 70
5.1 Market Overview by Therapeutic Application 70
5.2 Infectious Diseases 72
5.3 Oncology 73
5.4 Ophthalmology 74
5.5 Cardiovascular Disorders 75
5.6 Central Nervous System 76
5.7 Pulmonary Disorders 77
5.8 Orthopedics 78
5.9 Other Applications 79
6 Segmentation of Europe Market by Drug Type 80
6.1 Market Overview by Drug Type 80
6.2 Branded Prescription Drugs 82
6.3 Generic Prescription Drugs 83
6.4 OTC Drugs 84
7 European Market 2019-2026 by Country 85
7.1 Overview of European Market 85
7.2 UK 88
7.3 France 90
7.4 Germany 92
7.5 Spain 94
7.6 Italy 96
7.7 Russia 98
7.8 Rest of European Market 100
8 Competitive Landscape 102
8.1 Overview of Key Vendors 102
8.2 New Product Launch, Partnership, Investment, and M&A 105
8.3 Company Profiles 106
AbbVie Inc. 106
Astrazeneca 108
Aurobindo Pharma Ltd. 109
Bayer Healthcare 110
Bioniche Animal Health 111
Boehringer Ingelheim 112
Bristol-Myers Squibb 113
Ceva Animal Health, Inc. 114
Elanco Animal Health 115
Eli Lilly and Company 116
F. Hoffmann-La Roche 117
Glaxosmithkline PLC 118
Heska Co. 119
Lonza Group 120
Merck & Co., Inc. 121
Novartis International AG 122
Pfizer, Inc. 123
Ranbaxy Laboratories 124
Sanofi 125
Sun Pharmaceutical Industries Ltd. 126
9 Investing in Europe Market: Risk Assessment and Management 127
9.1 Risk Evaluation of Europe Market 127
9.2 Critical Success Factors (CSFs) 130
Related Reports and Products 133
Table 2. Main Product Trends and Market Opportunities in Europe Active Pharmaceutical Ingredients (API) Market 27
Table 3. Europe Active Pharmaceutical Ingredients (API) Market by Synthesis, 2015-2026, $ bn 35
Table 4. Europe Active Pharmaceutical Ingredients (API) Market: Synthetic API by Drug Type, 2015-2026, $ bn 37
Table 5. Europe Active Pharmaceutical Ingredients (API) Market: Biotech API by Drug Type, 2015-2026, $ bn 41
Table 6. Europe Active Pharmaceutical Ingredients (API) Market: Biotech API by Customer Base, 2015-2026, $ bn 46
Table 7. Europe Active Pharmaceutical Ingredients (API) Market: Biotech API by Expression Technology, 2015-2026, $ bn 49
Table 8. Europe Active Pharmaceutical Ingredients (API) Market: HPAPI by Drug Type, 2015-2026, $ bn 55
Table 9. Europe Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2015-2026, $ bn 58
Table 10. Europe Active Pharmaceutical Ingredients (API) Market: Captive Manufacturing by Drug Type, 2015-2026, $ bn 60
Table 11. Europe Active Pharmaceutical Ingredients (API) Market: Merchant Manufacturing by Drug Type, 2015-2026, $ bn 64
Table 12. Europe Active Pharmaceutical Ingredients (API) Market: Merchant Manufacturing by Drug Synthesis, 2015-2026, $ bn 67
Table 13. Europe Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2015-2026, $ bn 70
Table 14. Europe Active Pharmaceutical Ingredients (API) Market by Drug Type, 2015-2026, $ bn 80
Table 15. Europe Active Pharmaceutical Ingredients (API) Market by Country, 2015-2026, $ bn 87
Table 16. UK Active Pharmaceutical Ingredients (API) Market by Synthesis, 2015-2026, $ bn 89
Table 17. UK Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2015-2026, $ bn 89
Table 18. UK Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2015-2026, $ bn 89
Table 19. France Active Pharmaceutical Ingredients (API) Market by Synthesis, 2015-2026, $ bn 91
Table 20. France Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2015-2026, $ bn 91
Table 21. France Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2015-2026, $ bn 91
Table 22. Germany Active Pharmaceutical Ingredients (API) Market by Synthesis, 2015-2026, $ bn 93
Table 23. Germany Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2015-2026, $ bn 93
Table 24. Germany Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2015-2026, $ bn 93
Table 25. Spain Active Pharmaceutical Ingredients (API) Market by Synthesis, 2015-2026, $ bn 95
Table 26. Spain Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2015-2026, $ bn 95
Table 27. Spain Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2015-2026, $ bn 95
Table 28. Italy Active Pharmaceutical Ingredients (API) Market by Synthesis, 2015-2026, $ bn 97
Table 29. Italy Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2015-2026, $ bn 97
Table 30. Italy Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2015-2026, $ bn 97
Table 31. Russia Active Pharmaceutical Ingredients (API) Market by Synthesis, 2015-2026, $ bn 99
Table 32. Russia Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2015-2026, $ bn 99
Table 33. Russia Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2015-2026, $ bn 99
Table 34. Active Pharmaceutical Ingredients (API) Market in Rest of Europe by Country, 2015-2026, $ bn 101
Table 35. AbbVie Inc.: Company Snapshot 106
Table 36. AbbVie Inc.: Business Segmentation 106
Table 37. AbbVie Inc.: Product Portfolio 107
Table 38. AbbVie Inc.: Revenue, 2016-2018, $ bn 107
Table 39. AbbVie Inc.: Recent Developments 107
Table 40. Risk Evaluation for Investing in Europe Market, 2019-2026 128
Table 41. Critical Success Factors and Key Takeaways 131
Similar Reports
This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.
The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...
- Publish Date: March 2, 2020
- $0
Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...
- Publish Date: March 10, 2011
- $950
The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...
- Publish Date: July 18, 2011
- $950
